Torsdag 4 September | 11:55:50 Europe / Stockholm

Kalender

Est. tid*
2026-06-24 N/A Årsstämma
2026-03-05 08:00 Bokslutskommuniké 2025
2025-11-26 08:00 Kvartalsrapport 2025-Q3
2025-09-17 08:00 Kvartalsrapport 2025-Q2
2025-06-27 - Årsstämma
2025-06-27 - Kvartalsrapport 2025-Q1
2025-06-26 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2025-03-26 - Bokslutskommuniké 2024
2024-12-20 - Extra Bolagsstämma 2024
2024-11-27 - Kvartalsrapport 2024-Q3
2024-09-12 - Kvartalsrapport 2024-Q2
2024-06-28 - Kvartalsrapport 2024-Q1
2024-06-27 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2024-06-26 - Årsstämma
2024-03-20 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-09-26 - Kvartalsrapport 2023-Q2
2023-06-21 - Årsstämma
2023-06-21 - Kvartalsrapport 2023-Q1
2023-03-30 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2023-02-17 - Bokslutskommuniké 2022
2022-12-09 - Extra Bolagsstämma 2022
2022-10-26 - Kvartalsrapport 2022-Q3
2022-08-15 - Kvartalsrapport 2022-Q2
2022-04-28 - Kvartalsrapport 2022-Q1
2022-04-19 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 - Årsstämma
2022-02-16 - Bokslutskommuniké 2021
2021-12-29 - Extra Bolagsstämma 2021
2021-11-17 - Kvartalsrapport 2021-Q3
2021-09-08 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-04-14 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 - Årsstämma
2021-02-09 - Bokslutskommuniké 2020
2020-12-14 - Kvartalsrapport 2020-Q3
2020-09-30 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 - Årsstämma
2020-06-30 - Kvartalsrapport 2020-Q1
2019-12-20 - Extra Bolagsstämma 2019
2019-06-27 - Årsstämma
2019-06-03 - X-dag ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 - Split SOFTX 1:50

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo, Norge.
2025-08-26 14:35:51
Reference is made to SoftOx's press release dated 14 August 2025 concerning the
Equity Placement Facility Agreement with Long State Investments Ltd. ("Long
State"). Certain shareholders, referred to as the Lending Shareholders, have
entered into a share loan agreement (the "Agreement") with Long State. This
Agreement facilitates the lending of shares in SoftOx as part of the financing
facility, whereby certain shareholders will lend a total of 60 000 000 shares to
Long State over a period of 24 months from the start of the Equity Facility
Placement Agreement, unless extended in accordance with its terms.

The lending shareholders will not receive any compensation for lending shares to
Long State. However, SoftOx will reimburse them for documented expenses incurred
by banks or brokers related to transactions executed as a result of this loan
agreement.

The lending shareholders include the following primary insiders:

Sporcon Lifescience Advisors ApS, a company controlled by COB Ulrik Spork, has
agreed to lend Long State 30 000 000 shares under the Agreement. In addition to
the loaned shares, Sporcon Lifescience Advisors ApS holds 714 285 shares in
SoftOx.

Thomas Bjarnsholt Holding ApS, a company controlled by CEO Thomas Bjarnsholt,
has agreed to lend Long State 11 000 000 shares under the Agreement. In addition
to the loaned shares, Thomas Bjarnsholt Holding ApS holds 470 574 shares in
SoftOx.

Bonica AS, a company controlled by CFO Ingrid Juven, has agreed to lend Long
State 5 000 000 shares under the Agreement. In addition to the loaned shares,
Bonica AS holds 80 000 000 shares in SoftOx.

Enclosed with this announcement is the notification of transactions conducted by
individuals with managerial responsibilities and their closely associated
persons, in compliance with Regulation (EU) 2016/523.